Miquéias Lopes-Pacheco (Miqueias Lopes-Pacheco)

Scopus Author ID Loop profile ResearcherID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 29

Top Venues

Journal of personalized medicine

Cells

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Universidade de Lisboa

Federal University of Rio de Janeiro (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade de Lisboa Jul 01 2019

Portugal

Investigador Júnior :: Faculdade de Ciências/Departamento de Química e Bioquímica

Universidade de Lisboa

Portugal

Colaborador/Pós Doutor :: Instituto de Biossistemas e Ciências Integrativas

Universidade Federal do Rio de Janeiro

Brazil

Post Doc Fellow :: Instituto de Biofísica Carlos Chagas Filho

Education History

Federal University of Rio de Janeiro

Brazil

PHD :: Institute of Biophysics Carlos Chagas Filho

Federal University of Rio de Janeiro

Brazil

MSC :: Institute of Biophysics Carlos Bhagas Filho

Presidente Antônio Carlos University

Brazil

BSC

Publications

Claudia C Dos Santos, Miquéias Lopes-Pacheco, Karen English, Sara Rolandsson Enes, Anna D Krasnodembskaya, Patricia Rieken Macêdo Rocco
The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS. Cells 13 (2) (2024)
Claudia C Dos Santos, Miquéias Lopes-Pacheco, Karen English, Sara Rolandsson Enes, Anna D Krasnodembskaya, Patricia Rieken Macêdo Rocco
The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS. Cells 13 (2) (2024)
Filipa C Ferreira, Camilla Djenne Buarque, Miquéias Lopes-Pacheco
Organic Synthesis and Current Understanding of the Mechanisms of CFTR Modulator Drugs Ivacaftor, Tezacaftor, and Elexacaftor. Molecules (Basel, Switzerland) 29 (4) (2024)
Mafalda Bacalhau, Mariana Camargo, Miquéias Lopes-Pacheco
Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis. Journal of personalized medicine 14 (1) (2024)
Mafalda Bacalhau, Mariana Camargo, Miquéias Lopes-Pacheco
Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis. Journal of personalized medicine 14 (1) (2024)
Mafalda Bacalhau, Mariana Camargo, Miquéias Lopes-Pacheco
Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis. Journal of personalized medicine 14 (1) (2024)
Ana Acacia Sá Pinheiro, Ana Claudia Torrecilhas, Bruno Solano de Freitas Souza, Fernanda Ferreira Cruz, Herbert Leonel de Mattos Guedes, Tadeu Diniz Ramos, Miquéias Lopes-Pacheco, Celso Caruso-Neves, Patricia Rieken Macêdo Rocco
Potential of extracellular vesicles in the pathogenesis, diagnosis and therapy for parasitic diseases. Journal of extracellular vesicles 13 (8) (2024)
Ana Acacia Sá Pinheiro, Ana Claudia Torrecilhas, Bruno Solano de Freitas Souza, Fernanda Ferreira Cruz, Herbert Leonel de Mattos Guedes, Tadeu Diniz Ramos, Miquéias Lopes-Pacheco, Celso Caruso-Neves, Patricia Rieken Macêdo Rocco
Potential of extracellular vesicles in the pathogenesis, diagnosis and therapy for parasitic diseases. Journal of extracellular vesicles 13 (8) (2024)
Filipa C Ferreira, Camilla Djenne Buarque, Miquéias Lopes-Pacheco
Organic Synthesis and Current Understanding of the Mechanisms of CFTR Modulator Drugs Ivacaftor, Tezacaftor, and Elexacaftor. Molecules (Basel, Switzerland) 29 (4) (2024)
Filipa C Ferreira, Camilla Djenne Buarque, Miquéias Lopes-Pacheco
Organic Synthesis and Current Understanding of the Mechanisms of CFTR Modulator Drugs Ivacaftor, Tezacaftor, and Elexacaftor. Molecules (Basel, Switzerland) 29 (4) (2024)
Claudia C Dos Santos, Miquéias Lopes-Pacheco, Karen English, Sara Rolandsson Enes, Anna D Krasnodembskaya, Patricia Rieken Macêdo Rocco
The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS. Cells 13 (2) (2024)
Claudia C Dos Santos, Miquéias Lopes-Pacheco, Karen English, Sara Rolandsson Enes, Anna D Krasnodembskaya, Patricia Rieken Macêdo Rocco
The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS. Cells 13 (2) (2024)
Mafalda Bacalhau, Filipa C Ferreira, Iris A L Silva, Camilla Djenne Buarque, Margarida Duarte Amaral, Miquéias Lopes-Pacheco
Additive Potentiation of R334W-CFTR Function by Novel Small Molecules. Journal of personalized medicine 13 (1) (2023)
Mafalda Bacalhau, Filipa C Ferreira, Iris A L Silva, Camilla Djenne Buarque, Margarida Duarte Amaral, Miquéias Lopes-Pacheco
Additive Potentiation of R334W-CFTR Function by Novel Small Molecules. Journal of personalized medicine 13 (1) (2023)
Mafalda Bacalhau, Mariana Camargo, Grace A V Magalhães-Ghiotto, Sybelle Drumond, Carlos Henrique M Castelletti, Miquéias Lopes-Pacheco
Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Kathryn E Oliver, Marianne S Carlon, Nicoletta Pedemonte, Miquéias Lopes-Pacheco
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold? Expert opinion on pharmacotherapy (2023)
Mafalda Bacalhau, Mariana Camargo, Grace A V Magalhães-Ghiotto, Sybelle Drumond, Carlos Henrique M Castelletti, Miquéias Lopes-Pacheco
Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Mafalda Bacalhau, Mariana Camargo, Grace A V Magalhães-Ghiotto, Sybelle Drumond, Carlos Henrique M Castelletti, Miquéias Lopes-Pacheco
Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Mafalda Bacalhau, Filipa C Ferreira, Iris A L Silva, Camilla Djenne Buarque, Margarida Duarte Amaral, Miquéias Lopes-Pacheco
Additive Potentiation of R334W-CFTR Function by Novel Small Molecules. Journal of personalized medicine 13 (1) (2023)
Kathryn E Oliver, Marianne S Carlon, Nicoletta Pedemonte, Miquéias Lopes-Pacheco
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold? Expert opinion on pharmacotherapy (2023)
Mafalda Bacalhau, Filipa C Ferreira, Iris A L Silva, Camilla Djenne Buarque, Margarida Duarte Amaral, Miquéias Lopes-Pacheco
Additive Potentiation of R334W-CFTR Function by Novel Small Molecules. Journal of personalized medicine 13 (1) (2023)
Sang Hyun Lim, Jamie Snider, Liron Birimberg-Schwartz, Wan Ip, Joana C Serralha, Hugo M Botelho, Miquéias Lopes-Pacheco, Madalena C Pinto, Mohamed Taha Moutaoufik, Mara Zilocchi, Onofrio Laselva, Mohsen Esmaeili, Max Kotlyar, Anna Lyakisheva, Priscilla Tang, Lucía López Vázquez, Indira Akula, Farzaneh Aboualizadeh, Victoria Wong, Ingrid Grozavu, Teuta Opačak-Bernardi, Zhong Yao, Meg Mendoza, Mohan Babu, Igor Jurisica, Tanja Gonska, Christine E Bear, Margarida D Amaral, Igor Stagljar
CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system. Molecular systems biology 18 (2) (2022)
Iris A L Silva, Onofrio Laselva, Miquéias Lopes-Pacheco
Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis. Journal of personalized medicine 12 (8) (2022)
Miquéias Lopes-Pacheco, Mafalda Bacalhau, Sofia S Ramalho, Iris A L Silva, Filipa C Ferreira, Graeme W Carlile, David Y Thomas, Carlos M Farinha, John W Hanrahan, Margarida D Amaral
Rescue of Mutant CFTR Trafficking Defect by the Investigational Compound MCG1516A. Cells 11 (1) (2022)
Mariana A Antunes, Miquéias Lopes-Pacheco, Patricia Rieken Macêdo Rocco
Oxidative Stress-Derived Mitochondrial Dysfunction in Chronic Obstructive Pulmonary Disease: A Concise Review. Oxidative medicine and cellular longevity 2021 (2021)
Miquéias Lopes-Pacheco, Nicoletta Pedemonte, Guido Veit
Discovery of CFTR modulators for the treatment of cystic fibrosis. Expert opinion on drug discovery 16 (8) (2021)
Madalena C Pinto, Iris A L Silva, Miriam F Figueira, Margarida D Amaral, Miquéias Lopes-Pacheco
Pharmacological Modulation of Ion Channels for the Treatment of Cystic Fibrosis. Journal of experimental pharmacology 13 (2021)
Johnatas D Silva, Ligia L de Castro, Cassia L Braga, Gisele P Oliveira, Stefano A Trivelin, Carlos M Barbosa-Junior, Marcelo Marcos Morales, Claudia C Dos Santos, Daniel J Weiss, Miquéias Lopes-Pacheco, Fernanda F Cruz, Patricia Rieken Macêdo Rocco
Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology. Stem cells international 2019 (2019)
Miquéias Lopes-Pacheco, Inna Sabirzhanova, Daniele Rapino, Marcelo M Morales, William B Guggino, Liudmila Cebotaru
Correctors Rescue CFTR Mutations in Nucleotide-Binding Domain 1 (NBD1) by Modulating Proteostasis. Chembiochem : a European journal of chemical biology 17 (6) (2016)

Miquéias Lopes-Pacheco.css-eqlu8i{font-size:small;padding-left:4px;} (Miqueias Lopes-Pacheco)

Publication Activity (10 Years)

Top Topics

Top Venues

Miquéias Lopes-Pacheco (Miqueias Lopes-Pacheco)